NASDAQ:TXG | EBITDA | 10x Genomics, Inc.

Complete source-backed ebitda history.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$7.09M
2025-12-31-$9.48M
2025-03-31-$31.31M
2024-12-31-$41.09M
2024-03-31-$52.3M
2023-12-31-$45.47M
2023-03-31-$45.51M
2022-12-31-$16.58M
2022-03-31-$35.54M
2021-12-31-$10.05M
2021-03-31-$5.46M
2020-12-31-$405.67M
2020-03-31-$16.7M
2019-12-31-$5.24M
2019-03-31-$2M
2018-12-31-$74.08M

Annual EBITDA

DateEBITDA
2025-12-31-$24.79M
2024-12-31-$158.68M
2023-12-31-$229.82M
2022-12-31-$142.58M
2021-12-31-$31.14M
2020-12-31-$520.13M
2019-12-31-$23.51M
2018-12-31-$106.86M
2017-12-31-$14.07M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.